We advised Mirion Technologies on its $425 million stock offering and concurrent $375 million convertible notes offering

Davis Polk advised Mirion Technologies, Inc. in connection with a $425 million SEC-registered offering of 19,906,322 shares of its Class A common stock (which included 2,596,476 shares of Class A common stock pursuant to the exercise in full of the underwriters’ option to purchase additional shares) and a Rule 144A offering of an aggregate principal amount of $375 million of its 0.00% convertible senior notes due 2031 (which included $50 million principal amount of notes pursuant to the exercise in full of the initial purchasers’ option to purchase additional notes). In addition, Davis Polk advised the company on the capped call transactions entered into in connection with the offering.

Headquartered in Atlanta, Georgia, Mirion is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets.

The Davis Polk corporate team included partner Alan F. Denenberg and associates Dana Lueck-Mammen, Sunny Xu and Ashley Jaworoski. The equity derivatives team included partner Caitlin L. Wood and associate Alexander S. Pettingell. The tax team included partner Lucy W. Farr and associates William Liang and Fred Fu. Members of the Davis Polk team are based in the Northern California and New York offices.

Copy link to share post